TheraRadar
← Back
Data updated: Mar 29, 2026

WOCKHARDT

Infectious DiseaseGastroenterologyDermatology
Generics

WOCKHARDT is a generic drug manufacturer focused on Infectious Disease, Gastroenterology, Dermatology.

1979
Since
36
Drugs
-
Trials
239
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
TRETINOIN 2026-02-10
CARBIDOPA, LEVODOPA AND ENTACAPONE 2026-02-05
AMLODIPINE BESYLATE 2026-01-26
Manufacturing (CMC)
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
AMLODIPINE BESYLATE 2026-01-22
EXTENDED PHENYTOIN SODIUM 2026-01-02
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 39%
1 drugs Phase 3: 2 Phase 2: 1 Phase 1: 2
Gastroenterology 26%
2 drugs
Dermatology 22%
1 drugs Phase 3: 1
Respiratory 13%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology, Respiratory
PHARMACIA AND UPJOHN big-pharma
Dermatology, Infectious Disease, Respiratory
LEDERLE big-pharma
Infectious Disease, Dermatology, Respiratory
EXTROVIS big-pharma
Infectious Disease, Dermatology, Respiratory, Gastroenterology